Stock Scorecard



Stock Summary for Organovo Holdings Inc (ONVO) - $0.35 as of 11/20/2024 8:32:33 PM EST

Total Score

9 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ONVO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ONVO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ONVO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ONVO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ONVO (20 out of 90)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 6
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0

Latest News for for ONVO

Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - Organovo Holdings ( NASDAQ:ONVO ) 11/20/2024 1:05:00 PM
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting 11/20/2024 1:05:00 PM
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases - Organovo Holdings ( NASDAQ:ONVO ) 11/13/2024 1:06:00 PM
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases 11/13/2024 1:06:00 PM
Global 3D Printing Medical Devices Market to Evolve at a Phenomenal 17.1% CAGR through 2031 | SkyQuest Technology 10/16/2024 11:45:00 AM
Organ-On-Chip Market Size is Projected to Reach USD 587.02 million by 2032, Growing at a CAGR of 30.76%: Straits Research 8/20/2024 3:55:00 PM
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July - ASLAN Pharma ( NASDAQ:ASLN ) 7/18/2024 11:55:00 AM
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis 7/16/2024 12:05:00 PM
Organovo ( NASDAQ:ONVO ) Research Coverage Started at StockNews.com 7/13/2024 8:43:00 AM
Organovo ( NASDAQ:ONVO ) Earns Sell Rating from Analysts at StockNews.com 7/5/2024 11:46:00 AM

Financial Details for ONVO

Company Overview

Ticker ONVO
Company Name Organovo Holdings Inc
Country USA
Description Organovo Holdings, Inc., a biotechnology company, is focused on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in Solana Beach, California.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 9/30/2024
Next Earnings Date 2/6/2025

Stock Price History

Last Day Price 0.35
Price 4 Years Ago 12.30
Last Day Price Updated 11/20/2024 8:32:33 PM EST
Last Day Volume 582,403
Average Daily Volume 95,498
52-Week High 1.74
52-Week Low 0.32
Last Price to 52 Week Low 9.38%

Valuation Measures

Trailing PE N/A
Industry PE 120.49
Sector PE 40.32
5-Year Average PE -1.95
Free Cash Flow Ratio 1.67
Industry Free Cash Flow Ratio 15.59
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.98
Total Cash Per Share 0.21
Book Value Per Share Most Recent Quarter 0.36
Price to Book Ratio 1.75
Industry Price to Book Ratio 5.50
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 56.69
Industry Price to Sales Ratio Twelve Trailing Months 20.11
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 15,365,800
Market Capitalization 5,378,030
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 15.00%
Reported EPS 12 Trailing Months -1.04
Reported EPS Past Year -0.37
Reported EPS Prior Year -2.01
Net Income Twelve Trailing Months -12,542,000
Net Income Past Year -14,671,000
Net Income Prior Year -17,259,000
Quarterly Revenue Growth YOY -48.00%
5-Year Revenue Growth -48.57%
Operating Margin Twelve Trailing Months -86.93

Balance Sheet

Total Cash Most Recent Quarter 3,200,000
Total Cash Past Year 2,900,000
Total Cash Prior Year 5,295,000
Net Cash Position Most Recent Quarter 3,200,000
Net Cash Position Past Year 2,900,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 3,601,000
Total Stockholder Equity Prior Year 6,182,000
Total Stockholder Equity Most Recent Quarter 3,680,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -11,831,000
Free Cash Flow Per Share Twelve Trailing Months -0.77
Free Cash Flow Past Year -14,695,000
Free Cash Flow Prior Year -12,804,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.02
20-Day Bollinger Lower Band 0.35
20-Day Bollinger Middle Band 0.53
20-Day Bollinger Upper Band 0.71
Beta 0.61
RSI 31.46
50-Day SMA 0.85
150-Day SMA 1.72
200-Day SMA 3.44

System

Modified 11/19/2024 9:17:18 AM EST